pramipexole has been researched along with duloxetine hydrochloride in 2 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (duloxetine hydrochloride) | Trials (duloxetine hydrochloride) | Recent Studies (post-2010) (duloxetine hydrochloride) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 1,887 | 441 | 1,073 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bandettini di Poggio, M; Bruno, C; Meschini, MC; Nesti, C; Santorelli, FM; Schenone, A | 1 |
2 other study(ies) available for pramipexole and duloxetine hydrochloride
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation.
Topics: Benzothiazoles; DNA Mutational Analysis; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Dopamine Agonists; Duloxetine Hydrochloride; Dysarthria; Female; Hereditary Sensory and Motor Neuropathy; Humans; Middle Aged; Mitochondria; Ophthalmoplegia; Parkinson Disease; Pramipexole; Thiophenes; Tomography, Emission-Computed, Single-Photon | 2013 |